Search for Clinical Trial Results
Amyloidosis - 257 Studies Found
Status | Study |
Completed |
Study Name: Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis Condition: Amyloidosis Date: 2006-03-01 Interventions: Drug: VELCADE Once weekly at: 0.7, 1.0, 1.3 or 1.6 mg/m2 |
Recruiting |
Study Name: Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis Condition: Cardiac Amyloidosis Date: 2016-06-09 |
Recruiting |
Study Name: The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis Condition: Cardiac Amyloidosis Date: 2017-01-31 Interventions: Drug: F-18 florbetapir Cardiac PET images will be obtained following injection of F-18 labeled Florbetap |
Recruiting |
Study Name: Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis Condition: Dialysis Amyloidosis Date: 2016-10-30 Interventions: Device: Lixelle® treatment The treatment will be performed with the Lixelle® column connected |
Recruiting |
Study Name: Thalidomide/Dexamethasone Treatment And PET Evaluation In Organ Involvemenet of Cardiac Amyloidosis Condition: Cardiac Amyloidosis Date: 2016-11-08 Interventions:
|
Completed |
Study Name: A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis Condition: TTR-mediated Amyloidosis Date: 2014-11-10 Interventions: Drug: Revusiran (ALN-TTRSC) |
Completed |
Study Name: Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis Condition: TTR-mediated Amyloidosis Date: 2012-06-07 Interventions: Drug: ALN-TTR02 Ascending doses of ALN-TTR02 administered by intravenous (IV) infusion |
Completed |
Study Name: Phase 2 Study to Evaluate ALN-TTRSC (Revusiran) in Patients With Transthyretin (TTR) Cardiac Amyloidosis Condition: TTR-mediated Amyloidosis Date: 2013-11-06 Interventions: Drug: ALN-TTRSC (revusiran) for subcutaneous administration |
Completed |
Study Name: Trial to Evaluate Safety and Tolerability of ALN-TTR01 in Transthyretin (TTR) Amyloidosis Condition: Transthyretin Mediated Amyloidosis (ATTR) Date: 2010-06-21 Interventions:
|
Active, not recruiting |
Study Name: The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis Condition: Primary Systemic (AL) Amyloidosis Date: 2014-12-02 Interventions:
|